BCRX Jun 2024 5.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:34AM EDT. Market open.
| Previous close | 1.4600 |
| Open | 1.1500 |
| Bid | 1.2500 |
| Ask | 1.4000 |
| Strike | 5.00 |
| Expiry date | 2024-06-21 |
| Day's range | 1.1500 - 1.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.06k |
GuruFocus.comInsider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
Helen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 14, 2024.
GuruFocus.comDirector Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
GuruFocus.comInsider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 13, 2024.
© 2024 Yahoo. All rights reserved.